Literature DB >> 11465100

Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.

A Godkin1, N Jeanguet, M Thursz, P Openshaw, H Thomas.   

Abstract

The CD4+ T cell response is of critical importance in determining the fate of many viral infections. Clearance of HCV has a strong association with the MHC class II antigen HLA-DR11 suggesting a key role for CD4+ T cells. We used an epitope-prediction program to identify multiple novel HLA-DR11-restricted epitopes derived from several HCV proteins. These epitopes then allowed us to explore the qualitative and quantitative aspects of specific CD4+ T cell responses in HLA-DR11+ patients. Irrespective of the time since viral clearance, all the non-viremic patients recognized four epitopes with a high frequency of IFN-gamma-producing memory CD4+ T cells. There appeared to be two subpopulations of memory cells, immediate "effector" memory cells (Th1 phenotype) and resting "central" memory cells (Th1/0). Chronically infected patients revealed an almost complete absence of HCV epitope-specific IFN-gamma-producing T cells. However, three of these epitopes induced IL-10 production (down-regulatory) raising the question as to whether these cells play a role in viral persistence. The frequency and phenotype of memory cells is likely to reflect the magnitude of the initial immune response, and suggests that a high frequency of IFN-gamma-secreting CD4+ T cells to multiple epitopes are important in clearance of HCV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465100     DOI: 10.1002/1521-4141(200105)31:5<1438::AID-IMMU1438>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.

Authors:  A Ulsenheimer; M Lucas; N P Seth; J Tilman Gerlach; N H Gruener; A Loughry; G R Pape; K W Wucherpfennig; H M Diepolder; P Klenerman
Journal:  J Viral Hepat       Date:  2006-10       Impact factor: 3.728

2.  Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia.

Authors:  Amitinder Kaur; Corrina L Hale; Bradley Noren; Nadine Kassis; Meredith A Simon; R Paul Johnson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.

Authors:  Cheryl L Day; Georg M Lauer; Gregory K Robbins; Barbara McGovern; Alysse G Wurcel; Rajesh T Gandhi; Raymond T Chung; Bruce D Walker
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

Authors:  J T Gerlach; A Ulsenheimer; N H Grüner; M-C Jung; W Schraut; C-A Schirren; M Heeg; S Scholz; K Witter; R Zahn; A Vogler; R Zachoval; G R Pape; H M Diepolder
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  CD4+ T cell responses in hepatitis C virus infection.

Authors:  Nasser Semmo; Paul Klenerman
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

6.  Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.

Authors:  Ye-Gui Jiang; Yu-Ming Wang; Tong-Hua Liu; Jun Liu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

8.  Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.

Authors:  Susanne Knapp; Branwen J W Hennig; Angela J Frodsham; Lyna Zhang; Simon Hellier; Mark Wright; Rob Goldin; Adrian V S Hill; Howard C Thomas; Mark R Thursz
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

9.  Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection.

Authors:  G C Harcourt; M Lucas; A J Godkin; M Kantzanou; R E Phillips; P Klenerman
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 10.  Immunopathogenesis of Hepatitis C Virus Infection.

Authors:  David E Kaplan
Journal:  Gastroenterol Clin North Am       Date:  2015-08-13       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.